Product Briefing Outline: Axcelis Technologies, has
launched an Optima HD ion implanter, powered by ‘Imax,' for extremely
high dose, low energy implant applications used for leading-edge memory
and logic devices. The Optima HD Imax according to the company is
designed to dramatically increase productivity and reduce low energy,
high dose process times by implanting clusters of boron, instead of
individual atoms. The first Imax-enabled Optima HD tools will begin
shipping by the end of the 2006.
Problem: As semiconductor devices scale, the
energy of the ion implant also scales. Very low energy implant, and
very advanced annealing technologies are required to produce Ultra
Shallow Junctions, or "USJs". Conventional implant systems cannot
perform to expected levels at low energy due to fundamental physical
limits in the extraction and transport of ion beams at low energy.
Cluster ions include many dopant atoms (N) per ion. In this way, the
implanter operates at a higher energy (N times the process energy)
which avoids the low energy extraction and transport limits.
Solution:
Axcelis has been exploring molecular source technology as a potential
candidate for extending low energy implant technology since the late
1990s. The company is using ‘ClusterIon' source technology from
SemEquip, a manufacturer of ion sources and ion delivery systems for
the OEM implanter market. The Optima HD Imax implants molecules of
B18H22 including 18 boron atoms, resulting in higher productivity than
users could achieve with traditional approaches, without the risk of
energy contamination associated with beam deceleration. This boost in
productivity enables chipmakers to adopt a number of emerging trends,
including dual poly gate applications for advanced memory devices and
ultra shallow junctions in logic chips.
Applications: High dose, low energy implant used for leading-edge memory and logic devices, (Dual Poly Gate & Ultra Shallow Junction).
Platform:
The Optima HD platform covers all traditional high dose implants while
providing mid dose applications overlap for versatility and capital
efficiency. It delivers implants using Axcelis' advanced spot beam
technology, designed for uniformity and repeatability. Axcelis'
proprietary ‘RadiusScan' endstation further enhances productivity and
enables the system to cover a broad dose range. Imax source technology
can be used on all standard Optima HD implanters.
Availability: 4Q 2006 onwards.